BiondVax Pharmaceuticals Ltd (BVXV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

GlobalData
19 Pages - GLDATA62535
$250.00

Summary

BiondVax Pharmaceuticals Ltd (BiondVax) is a biopharmaceutical company that develops and manufactures universal flu (influenza) vaccine to provide multi-strain, multi season and long-term protection against various flu viruses. The company's lead product Multimeric-001, has completed Phase II and two Phase I/II clinical trials that provides protection against human influenza virus strains, including seasonal influenza strains and pandemic influenza strains, such as swine flu and avian flu. The company’s partner portfolio comprise. The Tel Aviv Sourasky Medical Center – Ichilov Hospital, The Weizmann Institute of Science, The UNISEC Consortium, Hadassah University Medical Center – Hebrew University of Jerusalem and Kimron Veterinary Institute among others. BiondVax is headquartered in Ness Ziona, Israel.

BiondVax Pharmaceuticals Ltd (BVXV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

'

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BiondVax Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Monosol Enters Into Agreement With BiondVax To Develop Oral Delivery For Flu Vaccine 11
Equity Offering 12
BiondVax Pharma Completes Partial Exercise of Underwriter's Over Allotment Option for Public Offering of American Depositary Shares for USD10.2 Million 12
BiondVax Pharma Announces Public Offering Of Units For US$1.3 Million 13
Acquisition 14
Angels High Tech Investments Acquires 19.99% stake in BiondVax Pharma for USD2.8 Million 14
BiondVax Pharmaceuticals Ltd - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BiondVax Pharmaceuticals Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
BiondVax Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Monosol Enters Into Agreement With BiondVax To Develop Oral Delivery For Flu Vaccine 11
BiondVax Pharma Completes Partial Exercise of Underwriter's Over Allotment Option for Public Offering of American Depositary Shares for USD10.2 Million 12
BiondVax Pharma Announces Public Offering Of Units For US$1.3 Million 13
Angels High Tech Investments Acquires 19.99% stake in BiondVax Pharma for USD2.8 Million 14
BiondVax Pharmaceuticals Ltd, Key Competitors 16
BiondVax Pharmaceuticals Ltd, Key Employees 17

List of Figures
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
BiondVax Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
BiondVax Pharmaceuticals Ltd, Medical Devices Deals, 2011 to YTD 2017 9

$250.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838